Updated: June 13, 2026
About the program
Program type
Investment stage
Investment focus areas
Health
RegTech
SaaS
Consumer
Medical Device
Payment
PayTech
Biomarker
Insurtechs
Fintechs
B2b2c
FinTech
Network Effects
Proteomics
Enterprise
Recurring
IVD
Finance
B-To-C
Financial Services
Banking
Insurance
InsurTech
WealthTech
Aggregator
Collaboration Tools
B2C
Marketplaces
Bioimaging
Productivity Tools
Platform
Diagnostics
Finserv
Lending
Insuretech
MedTech
Bank
Software
Elephant
In Vitro Diagnostics
Marketplace
Med Device
Therapy
Whale
Medical Devices
Subscription
Location
Countries invested
Headquarters9 Place de la Madeleine, 75008, Paris, France
Investment offer
Check size$3,000,000 – $50,000,000
Funding requirements
We invest in software companies (Enterprise software, Digital Health, Fintech, Insurtech, B2C marketplaces) that are typically at Series A stage or above. We are a cross-stage and cross-border fund with ticket sizes ranging from US$2m to $50m. Our teams are based in London, Paris, New York, San Francisco, and Hong Kong and we invest in the EU, the UK, the US, and Israel.